Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis

Infection

Volumn 24, Issue 1, 1996, Pages 76-79

  Muellegger, R R ^a   Zoechling, N ^a   Schluepen, E M ^b   Soyer, H P ^a   Hoedl, S ^a   Kerl, H ^a   Volkenandt, M ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CEFTRIAXONE; MINOCYCLINE;

ADULT; ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; BORRELIA INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DERMATITIS; DRUG EFFICACY; DRUG MONITORING; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; SKIN BIOPSY;

ACRODERMATITIS; BORRELIA BURGDORFERI GROUP; DNA, BACTERIAL; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN DISEASES, BACTERIAL;

EID: 0030025512     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01780664     Document Type: Conference Paper

References (23)

1. Weber, K., Neubert, U.: Clinical features of early erythema migrans disease and related disorders. Zbl. Bakt. Hyg. A 263 (1986) 209-228.
2. Asbrink, E., Olsson, I., Hovmark, A.: Erythema chronicum migrans Afzelius in Sweden. A study on 231 patients. Zbl. Bakt. Hyg. A 263 (1986) 229-236.
3. Weber, K.: Therapy of cutaneous manifestations. In: Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer Verlag, Berlin-Heidelberg 1993, pp. 312-327.
4. Weber, K., Pfister, H. W.: Clinical management of Lyme borreliosis. Lancet 343 (1994) 1017-1020.
5. Weber, K., Preac Mursic, V., Neubert, U., Thurmayr, R., Herzer, P., Wilske, B., Schierz, G., Marget, W.: Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann. NY Acad. Sci. 539 (1988) 324-345.
6. Weber, K., Neubert, U., Thurmayr, R.: Antibiotic therapy in early erythema migrans disease and related disorders. Zbl. Bakt. Hyg. A 263 (1986) 377-388.
7. Preac-Mursic, V., Weber, K., Pfister, H. W., Wilske, B., Gross, B., Baumann, A., Prokop, J.: Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355-359.
8. Weber, K., Preac Mursic, V., Wilske, B., Thurmayr, R., Neubert, U., Scherwitz, C.: A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 18 (1990) 91-96.
9. Weber, K., Wilske, B., Preac Mursic, V., Thurmayr, R.: Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 21 (1993) 361-372.
10. Kuiper, H., van-Dam, A. P., Spanjaard, L., de-Jongh, B. M., Widjojokusumo, A., Ramselaar, T. C., Cairo, I., Vos, K., Dankert, J.: Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J. Clin. Microbiol. 32 (1994) 715-720.
11. Melchers, W., Meis, J., Rosa, P., Claas, E., Nohlmans, L., Koopman, R., Horrevorts, A., Galama, J.: Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J. Clin. Microbiol. 29 (1991) 2401-2406.
12. Schwartz, I., Wormser, G., Schwartz, J. J., Cooper, D., Weissensee, P., Gazumyan, A., Zimmermann, E., Goldberg, N. S., Bittker, S., Campbell, G. L., Pavia, C. S.: Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J. Clin. Microbiol. 30 (1992) 3082-3088.
13. Weber, K., Thurmayr, R.: Oral pencillin versus minocycline for the treatment of early Lyme borreliosis. Zbl. Bakt. Hyg. A Suppl. 18 (1989) 263-268.
14. Muellegger, R. R., Zoechling, N., Soyer, H. P., Hoedl, S., Wienecke, R., Volkenandt, M., Kerl, H.: No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch. Dermatol. 131 (1995) 678-682.
15. Hassler, D., Zoeller, L., Haude, M., Hufnagel, H. D., Heinrich, F., Sonntag, H. G.: Cefotaxime versus penicillin in the late stage of Lyme disease - prospective, randomized therapeutic study. Infection 18 (1990) 16-20.
16. Wienecke, R., Neubert, U., Volkenandt, M.: Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J. Cutan. Pathol. 20 (1993) 385-388.
17. Hansen, K., Asbrink, E.: Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J. Clin. Microbiol. 27 (1989) 545-551.
18. Dattwyler, R. J., Volkman, D. J., Luft, B. J., Halperin, J. J., Thomas, B. S., Golightly, M. G.: Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 319 (1988) 1441-1446.
19. Steere, A. C., Hutchinson, G. J., Rahn, D. W., Sigal, L. H., Craft, J. E., Desanna, E. T., Malawista, S. E.: Treatment of the early manifestations of Lyme disease. Ann. Intern. Med. 99 (1983) 22-26.
20. Asbrink, E., Hovmark, A.: Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann. NY Acad.Sci. 539 (1988) 4-15.
21. Langer, K., Diem, E.: Acrodermatitis chronica atrophicans und sklerodermiforme Hautveränderungen bei Borrelia-Infektion. Hautarzt 39 (1988) 647-651.
22. Steere, A. C.: Lyme disease. N. Engl. J. Med. 321 (1989) 586-596.
23. Johnson, R. C.: Lyme disease - past, present and future. In: Cevenini, R., Sambri, V., La Placa, M. (eds.): Advances in Lyme borreliosis research. Proceedings of the VIth International Conference on Lyme borreliosis. Bologna, Italy, June 19-22, 1994, pp. 1-6.